Cardiovascular Business

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply. #pharmacy

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. A group of specialists from all over the world shared their perspective on this ongoing cardiac #imaging trend.

For artificial intelligence to truly transform care, the healthcare industry has a lot of work to do. Jens Eldrup-Jorgensen, MD, a veteran vascular surgeon and member of the Society for Vascular Surgery explains in a guest editorial.

Example of automated segmentation and 3D modeling of a patient’s abdominal aortic aneurysm (AAA) from a CT scan for procedure pre-planning or to a print 3D model using the Materialise Mimics software at the recent Radiological Society of North America (RSNA) 2024 meeting. #RSNA #RSNA24 #RSNA2024

An additional 15 patients will now receive the titanium total artificial heart technology from BiVACOR as they wait for a permanent transplant.

🚨 Webinar Today 🚨 Understanding plaque burden in CAD patients is critical for better outcomes. But how can you do it more accurately? Join us today for an insightful discussion featuring two cardiologists as they explore: ✅ The benefits of coronary CTA + AI-driven plaque analysis
 ✅ How to assess cardiovascular event risks effectively
 ✅ Key takeaways from the 7-year ADVANCE-DK study Don’t miss this opportunity. Register now! https://ow.ly/ZJmJ50UtpNg

Boston Scientific is recalling the catheters associated with its POLARx Cryoablation System due to a heightened risk of esophageal injury. The company has updated the instructions for these catheters to help minimize the risk of any additional issues going forward. #EPeeps #EPlab

The new HeartBeam Inc. (NASDAQ: BEAT) technology was designed to help patients evaluate their own heart health in real time.

Joseph C. Wright, a longtime Merit Medical employee, resigned after unspecified allegations regarding his conduct were brought to light. He was named the company's new president back in May.

Artificial intelligence (AI) to guide novice ultrasound users to perform good diagnostic quality cardiac echo exams, where the AI shows where and how to place and hold the transducer and the movement the movement needed. The AI then tells the sonographer where to stop and hold, or change what they are doing before the system auto captures the ideal views from which the AI makes measurements. The AI is from Caption Health, which was purchased by GE Healthcare in 2023. The tech is shown here integrated into the GE Vscan point-of-care ultrasound (POCUS) system during a demo at the Radiology Society of North America (RSNA) 2024 meeting this month. #RSNA2024 #RSNA #RSNA24 #echofirst #ultrasound #HealthAI